Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin glargine fasting plasma glucose target assessment in Chinese adults with type 2 diabetes mellitus
ChiCTR-IPR-15006894Phase 4Completed
- Sponsor
- China-Japan Friendship Hospital
- Start
- Sep 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by China-Japan Friendship Hospital. Primary endpoint: Percentage of patients achieving HbA1c <7%. Started Sep 2015; status: completed.
02
Drugs
insulin glargine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-IPR-15006894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006894.